PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 13, 2026Frontiers in Cellular Neuroscience0 citationsOpen Access

Predicting stroke-associated infection in acute ischemic stroke patients treated by thrombolysis

XYXuanyue YuZWZiwei WangDCDong Chen

Key Points

  • The aim is to describe stroke-associated infection and identify its risk factors in acute ischemic stroke patients undergoing thrombolysis.
  • Included 836 acute ischemic stroke patients treated with thrombolysis from a single center.
  • Divided patients into training (586) and validation (250) cohorts.
  • Identified independent risk factors using logistic regression analyses.
  • Developed a predictive nomogram based on risk factors identified.
  • Assessed model performance with receiver operating characteristic and calibration curves.
  • 20.1% of patients developed stroke-associated infection (168 out of 836).
  • Common infections included pulmonary infections (58.93%) and upper respiratory tract infections (26.19%).
  • SAI patients had a longer median hospitalization duration (9 days vs. 8 days, p < 0.001).
  • Higher inpatient medical costs were seen in SAI patients (28114.04 RMB vs. 22292.84 RMB, p < 0.001).
  • Five independent risk factors for SAI were identified, and the nomogram showed good predictive performance (AUC 0.80 for training, 0.72 for validation).

Abstract

Background Acute ischemic stroke (AIS) remains one of the major contributors to mortality and disability worldwide. Stroke-associated infection (SAI) is one of the most frequent complications following AIS and has a substantial impact on clinical outcomes, being closely linked to unfavorable prognosis. This study aimed to provide a comprehensive description of SAI, identify independent risk factors, and develop a predictive nomogram for its early identification. Methods This study included 836 AIS patients of the Dalian Single-center Study on Intravenous Thrombolysis for Ischaemic Stroke (DATIS) cohort who received recombinant tissue-plasminogen activator-induced thrombolysis at Central Hospital of Dalian University of Technology between January 2018 and November 2021. Patients were divided into a training cohort ( n = 586, 70%) and a validation cohort ( n = 250, 30%). Composition and economic features of SAI was explored. Independent risk factors were identified using univariate, multivariate, and multimodal logistic regression analyses. A predictive nomogram was then developed based on these independent risk factors. Model performance was assessed with receiver operating characteristic curves, and calibration curves. Results Among the 836 enrolled patients, 168 (20.1%) developed SAI. Composition of 168 patients with SAI were: 99 pulmonary infections (58.93%), 44 upper respiratory tract infections (26.19%), 15 urinary tract infection (8.93%), 2 gastrointestinal tract infections (1.19%), 1 periodontal infection (0.60%), 1 conjunctival infection (0.60%), and 1 erysipela (0.60%). In addition, 5 patients (2.98%) had multi-site infections (4 pulmonary plus urinary tract infection, 1 pulmonary plus gastrointestinal tract infection). Compared with non-infected patients, the SAI group experienced a significantly longer median hospitalization duration 9 days, IQR (7, 10) vs. 8 days, IQR (7, 9), p 0.001 and incurred higher median inpatient medical costs 28114.04 RMB, IQR (23230.12, 33379.85) vs. 22292.84 RMB, IQR (19203.53, 25999.63), p 0.001. Five variables—higher modified Rankin Scale at admission, male sex, prolonged prothrombin time, elevated blood urea nitrogen and lower thyroid-stimulating hormone—were independent risk factors for SAI. The nomogram constructed based on above predictors achieved an area under the curve of 0.80 in the training cohort and 0.72 in the validation cohort. Calibration curves supported the model’s performance. Conclusion This prospective cohort study comprehensively described composition and economic features, identified risk factors and developed predictive nomogram for SAI in AIS patients receiving intravenous rt-PA. Early identification of high-risk patients may facilitate targeted interventions, potentially reducing infection-related complications and improving clinical outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yu et al. (2026) studied this question.

synapsesocial.com/papers/69b3aad702a1e69014ccb939https://doi.org/10.3389/fncel.2026.1761927
Ask AI
Helpful
Bookmark
Share
View Full Paper